Novel stable PACAP analogs with potent activity towards the PAC1 receptor-Reference-Cited by-同舟云学术

Novel stable PACAP analogs with potent activity towards the PAC1 receptor

Published:2008-06 Issue:6 Volume:29 Page:919-932
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Bourgault Steve,Vaudry David,Botia Béatrice,Couvineau Alain,Laburthe Marc,Vaudry Hubert,Fournier Alain

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference40 articles.

1. Converting a peptide into a drug: strategies to improve stability and bioavailability;Adessi;Curr Med Chem,2002

2. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems;Arimura;Jpn J Physiol,1998

3. Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38;Arimura;Ann N Y Acad Sci,2006

4. Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood–brain barrier;Banks;J Pharmacol Exp Ther,1993

5. Cerebellar cortical-layer-specific control of neuronal migration by pituitary adenylate cyclase-activating polypeptide;Cameron;Neuroscience,2007

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pituitary adenylate cyclase-activating polypeptide signalling as a therapeutic target in migraine;Nature Reviews Neurology;2024-09-10

2. PACAP sequence modifications modulate the peptide antimicrobial activity against bacterial pathogens affecting aquaculture;Fish & Shellfish Immunology;2024-05

3. Investigation of PACAP38 and PAC1 Receptor Expression in Human Retinoblastoma and the Effect of PACAP38 Administration on Human Y-79 Retinoblastoma Cells;Life;2024-01-26

4. Migraine Treatment: Towards New Pharmacological Targets;International Journal of Molecular Sciences;2023-07-31

5. The Potential of the Nose-to-Brain Delivery of PACAP for the Treatment of Neuronal Disease;Pharmaceutics;2023-07-28